ArticleJBMR plus2021
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease.
David B Vaught et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleJBMR plus2021
David B Vaught et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.